About Organosyn Life Sciences Private Limited
Data last updated:
Organosyn Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC150729. Its GSTIN is 36AABCO5121A1Z4 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹9.7 Cr. It is led by directors Manav Jassal and Sat Paul Jassal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hno 3 – 1 – 2 Plot No 17 Motivalley Goyal Colony Tirumalgherry Hyderabad 500015, Telangana, India – 500015.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.64 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.04 Cr (net margin 5%) and EBITDA of ₹3.01 Cr (EBITDA margin 7.4%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company is associated with 1 brand: Organosyn Lifesciences. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹24.89 Cr; the latest was in May 2021.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website organosyn.com.
Company details
CIN history
Organosyn Life Sciences has one previous CIN (Corporate Identification Number): U24100DL2011PTC223635. The current CIN is U24100TG2011PTC150729, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC150729 | Current |
| U24100DL2011PTC223635 | Previous |
Contact details
Organosyn Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is organosyn.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHno 3 – 1 – 2 Plot No 17 Motivalley Goyal Colony Tirumalgherry Hyderabad 500015, Telangana, India – 500015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Organosyn Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Organosyn Life Sciences operates one associated brand: ORGANOSYN LIFESCIENCES. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacture and marketing of pharmaceutical generic formulations and related services. | organosyn.com |
Business activity
The main business activity of Organosyn Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Organosyn Life Sciences Private Limited, buy the company report.
Financials of Organosyn Life Sciences Private Limited
FY 2025 filings availableOrganosyn Life Sciences Private Limited reported revenue of ₹40.64 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Organosyn Life Sciences Private Limited, buy the company report.
Board of directors of Organosyn Life Sciences Private Limited
Organosyn Life Sciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Jassal | Director | 29 Dec 2012 | 13 Years 10 Months | Current |
| Sat Paul Jassal Also directs: Evertogen Life Sciences Limited | Director | 08 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Organosyn Life Sciences Private Limited is audited by Rajiv K. Gawri & Co., for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajiv K. Gawri & Co., | FY 2023 | 008847N |
Shareholding
The shareholding of Organosyn Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Organosyn Life Sciences Private Limited, buy the company report.
Deals & funding
Organosyn Life Sciences Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹24.89 Cr; the latest was in May 2021.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2020 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Mar 2014 | Funding round | ₹3.12 Cr | Investors: 3 individuals |
| Apr 2013 | Funding round | ₹8.98 Cr | Investors: 2 individuals |
| Mar 2012 | Funding round | ₹7.28 Cr | Investors: 2 individuals |
To see the full deal history of Organosyn Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Organosyn Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Organosyn Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Organosyn Life Sciences has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
Organosyn Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCO5121A1Z4 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Organosyn Life Sciences Private Limited, buy the company report.
Recent activity
Organosyn Life Sciences Private Limited has 6 board changes on record since 2012: 2 appointments and 4 cessations. The latest: Sanjay Kumar Nayak ceased to be Director on 25 May 2021.
Frequently asked questions
Organosyn Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2011 (15+ years old) and is registered under CIN U24100TG2011PTC150729.
Organosyn Life Sciences has 2 current directors:
- Manav Jassal - Director
- Sat Paul Jassal - Director
The latest financial statements of Organosyn Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Organosyn Life Sciences is 36AABCO5121A1Z4, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Organosyn Life Sciences is U24100TG2011PTC150729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Organosyn Life Sciences was incorporated on 11 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Organosyn Life Sciences has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹24.89 Cr; the latest was in May 2021.
Sanjay Kumar Nayak ceased to be Director on 25 May 2021. Arun Prakash ceased to be Director on 20 Jul 2020. Raminder Kaur ceased to be Director on 20 Jul 2020. Organosyn Life Sciences has 6 board changes on record in total.
Organosyn Life Sciences can be reached through the website organosyn.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Organosyn Life Sciences is at Hno 3 – 1 – 2 Plot No 17 Motivalley Goyal Colony Tirumalgherry Hyderabad 500015, Telangana, India – 500015.